RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Evidence of Added Benefit with Edoxaban in Patients with Paroxysmal AF
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 9
SP 20
OP 22
DO 10.1177/155989771409010
UL http://mdc.sagepub.com/content/14/9/20.abstract
AB Among patients with atrial fibrillation (AF) treated with anticoagulants, differences in baseline characteristics only partially account for the differences in outcome by AF subtype. This article presents results of a secondary data analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation—Thrombolysis in Myocardial Infarction 48 trial [ENGAGE AF-TIMI 48; NCT00781391].